AI Insights · Timothy · January 2024
Top 5 Medical Apps on Android in Belarus for Q4 2023
Explore the performance of the top 5 medical apps on Android in Belarus for Q4 2023, with insights on downloads, revenue, and active users.
During the fourth quarter of 2023, the top 5 medical apps on the Android platform in Belarus showcased varying trends in downloads, revenue, and active users. Here is a detailed overview based on data from Sensor Tower.
Anatomy Learning - 3D Anatomy from 3D Medical OU saw fluctuating weekly revenue, peaking at $42 in late October and mid-November, with a slight dip to $9 in early December. Downloads started strong at 239 in late September but tapered off to 119 by the end of December. Active users peaked at 727 in early October, gradually declining to 476 by the end of the quarter.
Anatomy 3D Atlas by Catfish Animation Studio experienced a notable spike in weekly revenue, reaching $36 in early November, before settling around $7 by the end of December. Downloads showed a downward trend, starting at 157 in late September and ending at 33 in the last week of December. Active users also decreased from 338 in late September to 165 by quarter's end.
Sanford Guide from Antimicrobial Therapy, Inc. had a mixed performance in revenue, with a high of $37 in early October and fluctuating around $10 to $18 for most of the quarter. Downloads were minimal, peaking at 9 in late September and dropping to zero by the end of the quarter.
Afya Whitebook: Medicina from Afya Participações S.A. maintained consistent revenue, averaging around $15 to $18 weekly throughout the quarter. Downloads were negligible, with a brief peak of 3 in early December.
Body Temperature・Fever Tracker by Firehawk demonstrated steady revenue, with a slight peak at $17 in late October. Downloads increased towards the end of the quarter, reaching 217 in the final week of December. Active users also grew, peaking at 206 in early December and ending at 197 by the end of the quarter.
For more in-depth insights and data, visit Sensor Tower.